Impact of a Major Organizational Change on Employee Productivity and Mental Health
Condition(s) studied
Investigational drug(s) / intervention(s)
Employees exposed to a major hospital reorganisation: Occupational exposure
Study summary
The study investigates the short- and long-term impact of a major organizational change on employee health and productivity. Changes in organizations is a common aspect of modern work life in all sectors and public healthcare is no exception. However, emerging evidence suggests that organizational changes may be a potential stressor which can impact on employee well-being and contribute to stress-related health problems. Using a large-scale natural experiment, the overall aim of the study is to investigate the impact of a major organizational change that took place during 2016-19 on employee health and productivity. In addition, we aim to identify groups that may be at increased risk of experiencing negative consequences of the reorganization. These at-risk groups can in turn be candidates for extended preventive measures when planning future major organizational changes.
Eligibility
Primary outcome measure(s)
- Employee health measured by rate of absenteeism, use of health care services and redeemed drug prescriptions — 4 years in which the outcomes are measured monthly and form a time-series of observations for 2 years before and after workplace reorganization
Employee health will be assessed monthly as rate absenteeism from work, use of general and mental health care services, and redeemed psychotropic drug prescriptions. The data are derived from a combination of company records and registries provided by Statistics Denmark
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Aarhus University Hospital | Aarhus | Central Jutland |
More Aarhus University Hospital trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06354335 on ClinicalTrials.gov ↗ ← All trials in Denmark